Stock Events

Stock Events

BNB Plus 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Next
-19.12
-18.79
-18.46
-18.12
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow UDJ1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap19.48B
Illumina provides sequencing and array-based solutions for genetic analysis, competing in the biotechnology and diagnostics sectors similar to APDN.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with APDN's DNA-based technologies.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences offers sequencing systems that compete with APDN in the genomics and DNA sequencing markets.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories provides a range of products and systems used to separate complex chemical and biological materials, competing in the life sciences research and clinical diagnostics markets.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific offers a broad range of services and products, including analytical instruments and reagents, which compete with APDN's offerings in the life sciences sector.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with APDN in the molecular diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics provides comprehensive genetic testing solutions, competing with APDN in the DNA sequencing and genetic analysis market.
Adaptive Biotechnologies
ADPT
Mkt Cap2.28B
Adaptive Biotechnologies offers immune-driven medicine solutions, competing with APDN in the biotech sector focusing on genetic and molecular diagnostics.
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with the genetic technologies and services provided by APDN.

About

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
Show more...
CEO
Ms. Judith Murrah
Employees
26
Country
Germany
ISIN
US03815U6073

Listings

F
DE
UDJ1.F
MU
DE
UDJ1.MU
XNAS
US
BNBX
STU
DE
UDJ1.STU

0 Comments

Share your thoughts

FAQ

What is BNB Plus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BNB Plus stocks are traded under the ticker UDJ1.MU.
When is the next BNB Plus earnings date?▼
BNB Plus is going to release the next earnings report on May 07, 2026.
How many employees does BNB Plus have?▼
As of April 12, 2026, the company has 26 employees.
In which sector is BNB Plus located?▼
BNB Plus operates in the Other sector.
When did BNB Plus complete a stock split?▼
BNB Plus has not had any recent stock splits.
Where is BNB Plus headquartered?▼
BNB Plus is headquartered in Stony Brook, Germany.